Webinars

Learning Outcomes

Tuesday 10th September 2024 ‘Overview of T2 diabetes’

• To review the pathophysiology of type 2 diabetes and diabetes remission
• To explore the impact of therapeutic inertia on patient outcomes and the importance of early treatment optimisation using an individualised approach
• To explore HbA1c considerations
• To recognise the differences between compliance, adherence and concordance and to understand the features of concordant patient consultations

Wednesday 16th October 2024 ‘Identifying risk & clinical review of T2D: detection, diagnosis & standard care processes’

• To be confident in identifying those people who are at risk of
  type 2 diabetes
• To be confident in determining an accurate diagnosis of type 2 diabetes
• To be aware of the standards of care for type 2 diabetes
• To identify the various methods required for the monitoring of
  type 2 diabetes

Thursday 28th November 2024 ‘Introducing CRM: the relationship between cardiovascular, renal and metabolic systems in type 2 diabetes’

• Explore the interconnected relationship between conditions of the CRM system across type 2 diabetes
• Understand the wider impact and increased risks associated with having one or more conditions affecting the CRM system
• Consider the unmet clinical need related to CRM morbidity and mortality in patients with type 2 diabetes
• Understand how clinical guidance for type 2 diabetes has been updated to reflect the results of positive cardiovascular outcome trials
• Reflect on the overall goals of treatment and individualised care for patients with type 2 diabetes

Tuesday 7th January 2025 ‘Oral therapies for patients with T2 diabetes (part 1)’

• Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes
• Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs
• Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease
• Recognise the need to consider therapy specific factors and the individual patient’s circumstances when choosing between different oral therapies

Wednesday 12th February 2025 ‘Oral therapies for patients with T2 diabetes (part 2)’

• Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes
• Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs
• Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease
• Recognise the need to consider therapy specific factors and the individual patient’s circumstances when choosing between different oral therapies

Wednesday 19th March 2025 ‘ Promoting Effective Change’

• To understand how adopting a patient- centred approach can support people with effective change
• To explore potential conversational structure and tools that promote change
• To understand the stages of change model and the nature of ambivalence
• Holistic Approach to Care in Younger Adults with T2D

Tuesday 6th May 2025 ‘Younger Adults with T2 Diabetes- treating patients <40 years’

• The growing problem of T2 diabetes in younger adults
• The importance of early identification and management
• Psychosocial Considerations in younger adults with T2D

Wednesday 18th June 2025 TBC